Terms: = Skin cancer AND IL6ST, CDw130, 3572, ENSG00000134352, P40189, IL6R-beta, GP130-RAPS, GP130, CD130
35 results:
1. The clinical relevance of OSM in inflammatory diseases: a comprehensive review.
Wolf CL; Pruett C; Lighter D; Jorcyk CL
Front Immunol; 2023; 14():1239732. PubMed ID: 37841259
[TBL] [Abstract] [Full Text] [Related]
2. IL-30 ameliorates imiquimod and K14-VEGF induced psoriasis-like disease by inhibiting both innate and adaptive immunity disorders.
Liu X; Hu Z; Zhang J; Ma T; Wu W; Wei X; Wang Z; Zhen H; Zhou H; Huang N; Li J
Biochem Biophys Res Commun; 2021 Nov; 579():97-104. PubMed ID: 34597998
[TBL] [Abstract] [Full Text] [Related]
3. STAT3-mediated upregulation of the AIM2 DNA sensor links innate immunity with cell migration to promote epithelial tumourigenesis.
Dawson RE; Deswaerte V; West AC; Tang K; West AJ; Balic JJ; Gearing LJ; Saad MI; Yu L; Wu Y; Bhathal PS; Kumar B; Chakrabarti JT; Zavros Y; Oshima H; Klinman DM; Oshima M; Tan P; Jenkins BJ
Gut; 2022 Aug; 71(8):1515-1531. PubMed ID: 34489308
[TBL] [Abstract] [Full Text] [Related]
4. ["Point line anterograde dissection" for the safe preparation of supraclavicular flap].
Zhou J; Chen XH; Ma TY; Kuang YX; Zhou MJ; Cao LL; Wang XL; Cao L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Sep; 55(9):845-849. PubMed ID: 32911887
[No Abstract] [Full Text] [Related]
5. Several genotypes, one phenotype: PIK3CA/AKT1 mutation-negative hidradenoma papilliferum show genetic lesions in other components of the signalling network.
Pfarr N; Allgäuer M; Steiger K; Weichert W; Schirmacher P; Noske A; Stenzinger A
Pathology; 2019 Jun; 51(4):362-368. PubMed ID: 31010589
[TBL] [Abstract] [Full Text] [Related]
6. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations.
Chen J; Zhang Y; Petrus MN; Xiao W; Nicolae A; Raffeld M; Pittaluga S; Bamford RN; Nakagawa M; Ouyang ST; Epstein AL; Kadin ME; Del Mistro A; Woessner R; Jaffe ES; Waldmann TA
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3975-3980. PubMed ID: 28356514
[TBL] [Abstract] [Full Text] [Related]
7. Optimisation of steroid prophylaxis schedules in breast cancer patients receiving docetaxel chemotherapy-a survey of health care providers and patients.
Jacobs C; Hutton B; Mazzarello S; Smith S; Joy A; Amir E; Ibrahim MF; Gregario N; Daigle K; Eggert L; Clemons M
Support Care Cancer; 2015 Nov; 23(11):3269-75. PubMed ID: 25933700
[TBL] [Abstract] [Full Text] [Related]
8. Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis.
Wang Z; Liu JQ; Liu Z; Shen R; Zhang G; Xu J; Basu S; Feng Y; Bai XF
J Immunol; 2013 Mar; 190(5):2415-23. PubMed ID: 23345334
[TBL] [Abstract] [Full Text] [Related]
9. ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma.
Sanz-Moreno V; Gaggioli C; Yeo M; Albrengues J; Wallberg F; Viros A; Hooper S; Mitter R; Féral CC; Cook M; Larkin J; Marais R; Meneguzzi G; Sahai E; Marshall CJ
Cancer Cell; 2011 Aug; 20(2):229-45. PubMed ID: 21840487
[TBL] [Abstract] [Full Text] [Related]
10. The efficacy of hyperbaric oxygen therapy in the treatment of medically refractory soft tissue necrosis after penile brachytherapy.
Gomez-Iturriaga A; Crook J; Evans W; Saibishkumar EP; Jezioranski J
Brachytherapy; 2011; 10(6):491-7. PubMed ID: 21345742
[TBL] [Abstract] [Full Text] [Related]
11. Negative-pressure wound therapy for musculoskeletal tumor surgery.
Sakellariou VI; Mavrogenis AF; Papagelopoulos PJ
Adv Skin Wound Care; 2011 Jan; 24(1):25-30. PubMed ID: 21173588
[TBL] [Abstract] [Full Text] [Related]
12. New monoclonal antibodies against B-cell antigens: possible new strategies for diagnosis of primary cutaneous B-cell lymphomas.
Fanoni D; Tavecchio S; Recalcati S; Balice Y; Venegoni L; Fiorani R; Crosti C; Berti E
Immunol Lett; 2011 Jan; 134(2):157-60. PubMed ID: 20951741
[TBL] [Abstract] [Full Text] [Related]
13. Contribution of dermatologic surgery in war.
Henning JS; Firoz BF
Dermatol Surg; 2010; 36(1):1-7. PubMed ID: 19912278
[TBL] [Abstract] [Full Text] [Related]
14. Constitutive suppressor of cytokine signaling 3 expression confers a growth advantage to a human melanoma cell line.
Komyod W; Böhm M; Metze D; Heinrich PC; Behrmann I
Mol Cancer Res; 2007 Mar; 5(3):271-81. PubMed ID: 17374732
[TBL] [Abstract] [Full Text] [Related]
15. Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease.
Demetris AJ; Lunz JG; Specht S; Nozaki I
World J Gastroenterol; 2006 Jun; 12(22):3512-22. PubMed ID: 16773708
[TBL] [Abstract] [Full Text] [Related]
16. Expression of gp130 in tumors and inflammatory disorders of the skin: formal proof of its identity as CD146 (MUC18, Mel-CAM).
Schön M; Kähne T; Gollnick H; Schön MP
J Invest Dermatol; 2005 Aug; 125(2):353-63. PubMed ID: 16098047
[TBL] [Abstract] [Full Text] [Related]
17. Use of simple hematological, biochemical and clinical parameters to monitor response of multiple myeloma patients on high dose thalidomide therapy.
Uppal G; Raina V; Sharma A; Anand M; Kumar R; Khaitan BK; Grover JK
Indian J Cancer; 2005; 42(1):46-50. PubMed ID: 15805692
[TBL] [Abstract] [Full Text] [Related]
18. Induction of "antigen silencing" in melanomas by oncostatin M: down-modulation of melanocyte antigen expression.
Durda PJ; Dunn IS; Rose LB; Butera D; Benson EM; Pandolfi F; Kurnick JT
Mol Cancer Res; 2003 Apr; 1(6):411-9. PubMed ID: 12692260
[TBL] [Abstract] [Full Text] [Related]
19. Stage- and tissue-specific expression of a beta-1,4-galactosyltransferase in the embryonic epidermis.
Uehara K; Thelu J
In Vitro Cell Dev Biol Anim; 2001 Oct; 37(9):613-7. PubMed ID: 11710439
[TBL] [Abstract] [Full Text] [Related]
20. A panel immunoblot using co-incubated monoclonal antibodies for identification of melanoma cells.
Wang R; Dworak LJ; Lacy MJ
J Immunol Methods; 2001 Mar; 249(1-2):167-83. PubMed ID: 11226474
[TBL] [Abstract] [Full Text] [Related]
[Next]
